A detailed history of Institutional & Family Asset Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Institutional & Family Asset Management, LLC holds 330 shares of VRTX stock, worth $153,304. This represents 0.02% of its overall portfolio holdings.

Number of Shares
330
Previous 374 11.76%
Holding current value
$153,304
Previous $156,000 1.28%
% of portfolio
0.02%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 05, 2024

SELL
$392.81 - $485.53 $17,283 - $21,363
-44 Reduced 11.76%
330 $154,000
Q1 2024

May 08, 2024

SELL
$407.69 - $446.08 $15,899 - $17,397
-39 Reduced 9.44%
374 $156,000
Q4 2023

Feb 06, 2024

SELL
$343.0 - $410.68 $7,546 - $9,034
-22 Reduced 5.06%
413 $168,000
Q3 2023

Nov 13, 2023

SELL
$338.18 - $362.46 $6,763 - $7,249
-20 Reduced 4.4%
435 $151,000
Q2 2023

Aug 09, 2023

SELL
$314.42 - $351.91 $4,401 - $4,926
-14 Reduced 2.99%
455 $160,000
Q1 2023

May 08, 2023

SELL
$283.23 - $323.1 $5,947 - $6,785
-21 Reduced 4.29%
469 $147,000
Q4 2022

Feb 08, 2023

SELL
$285.76 - $321.48 $4,000 - $4,500
-14 Reduced 2.78%
490 $141,000
Q3 2022

Nov 07, 2022

SELL
$273.83 - $305.53 $15,060 - $16,804
-55 Reduced 9.84%
504 $146,000
Q2 2022

Aug 08, 2022

SELL
$234.96 - $292.55 $12,922 - $16,090
-55 Reduced 8.96%
559 $158,000
Q1 2022

May 11, 2022

SELL
$221.42 - $260.97 $1,107 - $1,304
-5 Reduced 0.81%
614 $160,000
Q1 2021

May 06, 2021

BUY
$207.02 - $241.31 $19,252 - $22,441
93 Added 17.68%
619 $133,000
Q4 2020

Feb 03, 2021

BUY
$207.01 - $276.09 $3,726 - $4,969
18 Added 3.54%
526 $124,000
Q3 2020

Oct 30, 2020

BUY
$255.65 - $303.1 $22,497 - $26,672
88 Added 20.95%
508 $138,000
Q2 2020

Aug 14, 2020

BUY
$225.48 - $295.8 $4,284 - $5,620
19 Added 4.74%
420 $122,000
Q1 2020

May 14, 2020

SELL
$199.77 - $247.81 $5,393 - $6,690
-27 Reduced 6.31%
401 $95,000
Q4 2019

Feb 14, 2020

SELL
$166.71 - $223.91 $833 - $1,119
-5 Reduced 1.15%
428 $94,000
Q3 2019

Nov 14, 2019

SELL
$166.23 - $187.09 $166 - $187
-1 Reduced 0.23%
433 $73,000
Q2 2019

Aug 14, 2019

BUY
$164.61 - $190.37 $1,975 - $2,284
12 Added 2.84%
434 $80,000
Q1 2019

May 13, 2019

SELL
$163.73 - $194.7 $2,783 - $3,309
-17 Reduced 3.87%
422 $78,000
Q1 2018

May 14, 2018

BUY
$151.6 - $177.13 $66,552 - $77,760
439 New
439 $72,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Institutional & Family Asset Management, LLC Portfolio

Follow Institutional & Family Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.